Panacea Acquisition Stock Quote NUVB - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

2.75

Bid

Ask

Volume

638,805

2.61 Day's Range 2.76

0.95 52 Week Range 4.1598

Market Cap

584.853M

Previous Close

2.62

Open

2.63

Last Trade

2.74

Last Trade Time

Financial Volume

$ 1,715,785

VWAP

2.6859

Average Volume (3m)

1,385,947

Shares Outstanding

219,046,219

Dividend Yield

PE Ratio

-7.71

Earnings Per Share (EPS)

-0.35

Revenue

Net Profit

-75.8M

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's proprietary portfolio includes around six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of t... Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's proprietary portfolio includes around six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

ecor1cap.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Panacea Acquisition Corp is listed in the Pharmaceutical Preparations sector of the New York Stock Exchange with ticker NUVB. The last closing price for Panacea Acquisition was $2.62. Over the last year, Panacea Acquisition shares have traded in a share price range of $ 0.95 to $ 4.1598.

Panacea Acquisition currently has 219,046,219 shares outstanding. The market capitalization of Panacea Acquisition is $584.85 million. Panacea Acquisition has a price to earnings ratio (PE ratio) of -7.71.

Nuvation Bio to Present Updated Data on Taletrectinib, a ROS1 inhibitor, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Nuvation Bio Inc. (NYSE: NUVB), a late-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.17	6.58914728682	2.58	2.79	2.505	1111757	2.64448023	CS
4	-0.91	-24.8633879781	3.66	3.865	2.505	1307226	3.09525581	CS
12	1.18	75.1592356688	1.57	4.1598	1.52	1385947	2.82456923	CS
26	1.6	139.130434783	1.15	4.1598	0.95	1360412	2.00599589	CS
52	1.12	68.7116564417	1.63	4.1598	0.95	962831	1.86932112	CS
156	-8.5	-75.5555555556	11.25	15.23	0.95	874079	4.29872941	CS
260	-7.25	-72.5	10	15.23	0.95	881751	4.8451445	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BDRXBiodexa Pharmaceuticals PLC	$ 1.3254 (82.86%)	70.82M
IBRXImmunityBio Inc	$ 7.35 (43.84%)	40.28M
AGENAgenus Inc	$ 11.685 (40.78%)	3.37M
ULHUniversal Logistics Holdings Inc	$ 45.63 (38.74%)	484.22k
NIVFNewGenIvf Group Ltd	$ 1.77 (36.15%)	57.78M
MFImF International Ltd	$ 2.3153 (-77.82%)	21.23M
NWGLNature Wood Group Ltd	$ 5.05 (-70.03%)	2.48M
ICLKiClick Interactive Asia Group Ltd	$ 1.21 (-52.17%)	719.95k
NUWENewellis Inc	$ 0.1695 (-41.35%)	18.46M
SGBXSafe and Green Holdings Corporation	$ 0.1469 (-32.92%)	8.39M
PEGYPineapple Energy Inc	$ 0.065499 (26.20%)	325.57M
SQQQProShares UltraPro Short QQQ	$ 11.43 (-4.75%)	137.28M
INTCIntel Corporation	$ 31.88 (-9.20%)	119.84M
TSLATesla Inc	$ 168.29 (-1.11%)	109.84M
SOFISoFi Technologies Inc	$ 7.87 (3.69%)	88.63M